DYAI Insider Trading
Insider Ownership Percentage: 29.50%
Insider Buying (Last 12 Months): $24,700.00
Insider Selling (Last 12 Months): $0.00
Dyadic International Share Price & Price History
Current Price: $1.00
Price Change: ▲ Price Increase of +0.0576 (6.11%)
As of 12/4/2025 05:00 PM ET
Dyadic International Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 8/1/2025 | Joseph P Hazelton | COO | Buy | 26,000 | $0.95 | $24,700.00 | 155,340 |  |
Dyadic International Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 11/17/2025 | Apis Capital Advisors LLC | 1,540,000 | $1.82M | 0.4% | N/A | 4.256% |  |
| 11/14/2025 | Marathon Capital Management | 35,000 | $41K | 0.0% | N/A | 0.097% | |
| 11/13/2025 | Landscape Capital Management L.L.C. | 160,654 | $0.19M | 0.0% | N/A | 0.444% | |
| 11/3/2025 | Truist Financial Corp | 326,200 | $0.39M | 0.0% | +30.5% | 0.901% | |
| 10/31/2025 | Perkins Capital Management Inc. | 348,050 | $0.41M | 0.4% | +627.4% | 0.962% | |
| 10/9/2025 | Chapin Davis Inc. | 932,004 | $1.10M | 0.3% | +5.6% | 2.575% | |
| 8/12/2025 | Bandera Partners LLC | 1,383,308 | $1.37M | 0.6% | -11.7% | 4.597% | |
| 8/12/2025 | AlphaCore Capital LLC | 50,759 | $50K | 0.0% | N/A | 0.169% | |
| 7/14/2025 | Chapin Davis Inc. | 882,849 | $0.87M | 0.2% | +4.7% | 2.934% | |
| 4/29/2025 | Callan Capital LLC | 50,759 | $69K | 0.0% | +86.8% | 0.169% | |
| 4/23/2025 | Chapin Davis Inc. | 842,849 | $1.14M | 0.4% | -2.9% | 2.801% | |
| 2/17/2025 | Millennium Management LLC | 16,193 | $28K | 0.0% | N/A | 0.055% | |
| 2/17/2025 | Bank of America Corp DE | 27,132 | $47K | 0.0% | +16,146.7% | 0.092% | |
| 2/14/2025 | Jane Street Group LLC | 25,711 | $45K | 0.0% | N/A | 0.087% | |
| 2/14/2025 | Two Sigma Securities LLC | 14,037 | $25K | 0.0% | N/A | 0.047% | |
| 1/31/2025 | Truist Financial Corp | 250,000 | $0.43M | 0.0% | N/A | 0.845% | |
| 1/24/2025 | Inlet Private Wealth LLC | 30,000 | $52K | 0.0% | N/A | 0.101% | |
| 10/8/2024 | Chapin Davis Inc. | 868,301 | $0.90M | 0.3% | +2.5% | 2.970% | |
| 7/19/2024 | Chapin Davis Inc. | 847,301 | $1.25M | 0.4% | +2.5% | 2.898% | |
| 5/3/2024 | Callan Capital LLC | 27,174 | $45K | 0.0% | N/A | 0.093% | |
| 1/11/2024 | Chapin Davis Inc. | 826,301 | $1.33M | 0.6% | -1.4% | 2.868% | |
| 11/8/2023 | Atria Wealth Solutions Inc. | 24,136 | $46K | 0.0% | N/A | 0.084% | |
| 8/30/2023 | Chapin Davis Inc. | 832,301 | $1.61M | 0.8% | +1.1% | 2.889% | |
| 7/10/2023 | AE Wealth Management LLC | 18,356 | $35K | 0.0% | N/A | 0.064% | |
| 2/13/2023 | Forefront Analytics LLC | 57,094 | $70K | 0.0% | +40.8% | 0.200% | |
| 1/30/2023 | Chapin Davis Inc. | 819,629 | $1.01M | 0.6% | N/A | 2.870% | |
| 11/14/2022 | Forefront Analytics LLC | 40,546 | $77K | 0.0% | -13.3% | 0.143% | |
| 8/10/2022 | Forefront Analytics LLC | 46,771 | $0.14M | 0.1% | +38.9% | 0.165% | |
| 5/4/2022 | Commonwealth Equity Services LLC | 28,018 | $84K | 0.0% | +37.6% | 0.099% | |
| 2/10/2022 | Teramo Advisors LLC | 10,000 | $45K | 0.0% | N/A | 0.036% | |
| 1/31/2022 | Commonwealth Equity Services LLC | 20,368 | $92K | 0.0% | +54.7% | 0.073% | |
| 11/12/2021 | Trexquant Investment LP | 47,287 | $0.26M | 0.0% | N/A | 0.168% | |
| 11/12/2021 | Jump Financial LLC | 17,204 | $96K | 0.0% | +42.2% | 0.061% | |
| 11/12/2021 | Geode Capital Management LLC | 209,427 | $1.16M | 0.0% | +18.1% | 0.746% | |
| 11/9/2021 | Barclays PLC | 10,387 | $58K | 0.0% | -27.2% | 0.037% | |
| 11/9/2021 | BlackRock Inc. | 251,646 | $1.40M | 0.0% | -2.9% | 0.896% | |
| 10/29/2021 | Commonwealth Equity Services LLC | 13,162 | $73K | 0.0% | -32.5% | 0.047% | |
| 8/17/2021 | Millennium Management LLC | 268,447 | $0.96M | 0.0% | N/A | 0.974% | |
| 8/16/2021 | State Street Corp | 55,350 | $0.20M | 0.0% | -82.8% | 0.201% | |
Data available starting January 2016
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial to demonstrate the safety in humans of a protein produced using the C1 platform. It has also developed the Dapibus thermophilic, a filamentous fungal-based microbial protein production platform to enable the development and large-scale manufacture of cost-effective proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, including food, nutrition, and wellness. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; Joint Development Agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Read More on Dyadic International
Volume
243,958 shs
Average Volume
527,406 shs
Market Capitalization
$36.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.24
Who are the company insiders with the largest holdings of Dyadic International?
Who are the major institutional investors of Dyadic International?
Which major investors are buying Dyadic International stock?
In the previous quarter, DYAI stock was bought by institutional investors including:
- Apis Capital Advisors LLC
- Perkins Capital Management Inc.
- Landscape Capital Management L.L.C.
- Truist Financial Corp
- Chapin Davis Inc.
- Marathon Capital Management
- Group One Trading LLC
